Loading...
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway. Correlations between polymorphisms and pharmacokinetic parameters and the occurrence of hepato- and myelotoxicity were studied. Single n...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5354739/ https://ncbi.nlm.nih.gov/pubmed/27566582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11543 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|